These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3527085)

  • 1. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.
    McGuigan LE; Prendergast JK; Geczy AF; Edmonds JP; Bashir HV
    Ann Rheum Dis; 1986 Jul; 45(7):566-71. PubMed ID: 3527085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis.
    Prendergast JK; McGuigan LE; Geczy AF; Kwong TS; Edmonds JP
    Infect Immun; 1984 Dec; 46(3):686-9. PubMed ID: 6334031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
    McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
    Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis.
    Geczy AF; McGuigan LE; Sullivan JS; Edmonds JP
    J Exp Med; 1986 Sep; 164(3):932-7. PubMed ID: 3528379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis.
    Edmonds J; Geczy AF; Sullivan JS; Prendergast JK; Upfold LI; Bashir HV
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):75-82. PubMed ID: 6606476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
    Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients.
    Beukelman CJ; van Leeuwen A; Aerts PC; van Kregten E; van Bree S; van Rood JJ; Willers JM; van Dijk H
    Br J Rheumatol; 1988; 27 Suppl 2():58-60. PubMed ID: 3261191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
    Singh B; Milton JD; Woodrow JC
    Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals.
    Orban P; Sullivan JS; Geczy AF; Upfold LI; Coulits N; Bashir HV
    Clin Exp Immunol; 1983 Jul; 53(1):10-6. PubMed ID: 6191893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a Klebsiella plasmid involved in the aetiology of Ankylosing Spondylitis in HLA-B27-positive individuals?
    Cameron FH; Russell PJ; Sullivan J; Geczy AF
    Mol Immunol; 1983 May; 20(5):563-6. PubMed ID: 6348514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.
    de Vries DD; Dekker-Saeys AJ; Gyodi E; Bohm U; Ivanyi P
    Ann Rheum Dis; 1992 Jun; 51(6):783-9. PubMed ID: 1616364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of anti-Klebsiella K43 antiserum and lymphocytes from HLA-B27-positive patients with ankylosing spondylitis.
    Struthers GR
    Lancet; 1985 Mar; 1(8431):764. PubMed ID: 2858037
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients.
    Archer JR; Stubbs MM; Geczy AF
    Clin Exp Rheumatol; 1988; 6(1):35-9. PubMed ID: 3260844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera.
    Avakian H; Welsh J; Ebringer A; Entwistle CC
    Br J Exp Pathol; 1980 Feb; 61(1):92-6. PubMed ID: 6990955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.